Showing results (71-80 of 226) with videos related to

Sort By:
Pageof 23
Journal of Immunotherapy with Emphasis on Tumor Immunology : Official Journal of the Society for Biological Therapy|February 1, 1994
Production of interleukin-2 by EL4 tumor cells induces natural killer cell- and T-cell-mediated immunityM J Visseren, M Koot, E I van der Voort, et al.
European Journal of Nuclear Medicine and Molecular Imaging|August 18, 2025
Can we obtain prognostic information from healthy tissue uptake and volume in baseline 18F-FDG PET/CT imaging in diffuse large B-cell lymphoma?Nienke R Gerards, Sanne E Wiegers, Anne L Bes, et al.
Diagnostics (Basel, Switzerland)|November 27, 2024
Feasibility of Using 18F-FDG PET/CT Radiomics and Machine Learning to Detect Drug-Induced Interstitial Lung DiseaseCharlotte L C Smith, Gerben J C Zwezerijnen, Sanne E Wiegers, et al.
Journal of Reproductive Immunology|February 1, 2020
Vaginal dysbiosis associated-bacteria Megasphaera elsdenii and Prevotella timonensis induce immune activation via dendritic cellsNienke H van Teijlingen, Leanne C Helgers, Esther M Zijlstra-Willems, et al.
Retrovirology|January 1, 2015
Caveolin-1 mediated uptake via langerin restricts HIV-1 infection in human Langerhans cellsLinda M van den Berg, Carla M S Ribeiro, Esther M Zijlstra-Willems, et al.
Diabetes|March 1, 1994
Beta 2-microglobulin-deficient NOD mice do not develop insulitis or diabetesL S Wicker, E H Leiter, J A Todd, et al.
Hematological Oncology|December 1, 2024
Safety and Efficacy of Tinostamustine in a Subpopulation of Patients With Relapsed/Refractory Hodgkin Lymphoma From a Phase I TrialAnna Sureda, Antonio Pinto, Hervé Ghesquières, et al.
Plos One|January 7, 2017
Performance of 89Zr-Labeled-Rituximab-PET as an Imaging Biomarker to Assess CD20 Targeting: A Pilot Study in Patients with Relapsed/Refractory Diffuse Large B Cell LymphomaYvonne W S Jauw, Josée M Zijlstra, Daphne de Jong, et al.
Frontiers in Medicine|August 24, 2023
Toll-like receptor 4 and Syk kinase shape dendritic cell-induced immune activation to major house dust mite allergensStefanie Busold, Jaap H Akkerdaas, Esther M Zijlstra-Willems, et al.
Blood Advances|September 18, 2023
Prognostic model using 18F-FDG PET radiomics predicts progression-free survival in relapsed/refractory Hodgkin lymphomaJulia Driessen, Gerben J C Zwezerijnen, Heiko Schöder, et al.
Pageof 23